2023-10-19T14:09:24-05:00 2022-12-31 571157523 APRIO LLP 111 ROCKVILLE PIKE SUITE 600 ROCKVILLE MD 20850 990 2022-01-01 453824067 BIOHEALTH INNOVATION BIOH 3016370699 1 CHURCH STREET 801 ROCKVILLE MD 20850 RICHARD BENDIS PRESIDENT & CEO 3016370699 2023-10-19 1 RICHARD BENDIS 999009999 0 STACY CULLEN P00974308 3012316200 2023-10-19 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z RICHARD BENDIS 1 CHURCH STREET 801 ROCKVILLE MD 20850 4065006 0 X WWW.BIOHEALTHINNOVATION.ORG X 2011 MD CONNECTS MARKET RELEVANT RESEARCH ASSETS TO APPROPRIATE FINDING, MANAGEMENT, AND MARKETS TO FACILITATE THE DEVELOPMENT OF COMMERCIALLY VIABLE BIO HEALTH PRODUCTS. 24 23 14 24 0 0 2936434 3404859 867591 660147 0 0 0 0 3804025 4065006 0 0 0 0 1929364 2029059 0 0 525347 1265839 1657714 3195203 3686773 608822 378233 5134155 5438812 435356 344877 4698799 5093935 X BIOHEALTH INNOVATION CONNECTS MARKET RELEVANT RESEARCH ASSETS TO APPROPRIATE FUNDING, MANAGEMENT, AND MARKETS TO FACILITATE THE DEVELOPMENT OF COMMERCIALLY VIABLE BIO HEALTH PRODUCTS AND COMPANIES. 0 0 2752127 660147 ENTREPRENEUR-IN-RESIDENCE/SMALL BUSINESS INNOVATIVE RESEARCH(SBIR): THE BHI SBIR/STTR FEDERAL FUNDING ASSISTANCE OFFERS BIOHEALTH COMPANIES SUPPORT IN PREPARING APPLICATIONS FOR FEDERAL FUNDING INCLUSIVE OF SBIRS, STTRS, AND OTHER FEDERAL GOVERNMENT AWARDS. BHI'S ENTREPRENEUR-IN-RESIDENCE (EIR)POGRAM IS DESIGNED TO BE AN ACTIVE PARTNER WITH RESEARCH INSTITUTIONS TO SOURCE, FUND, AND GROW HIGH-POTENTIAL, EARLY-STAGE PRODUCTS THROUGH PROJECT-FOCUSED COMPANIES. THE ENTREPRENEURS IN THE PROGRAM SUPPORT THE FORMATION OF NEW COMPANIES BASED UPON INNOVATIVE DISCOVERIES IN THE AREAS OF DRUGS, VACCINES, THERAPEUTICS, DIAGNOSTICS, AND MEDICAL DEVICES FROM THE INTRAMURAL RESEARCH PROGRAMS AT PARTNER ORGANIZATIONS, AS WELL AS FROM UNIVERSITIES AND BUSINESSES. THE EIR WILL FIND, EVALUATE, AND SUPPORT THE DEVELOPMENT OF NEW START-UP COMPANIES BASED UPON TECHNOLOGY LICENSE AGREEMENTS FROM TECHNOLOGY TRANSFER OFFICES OR EQUIVALENT UNITS WITHIN THE RESEARCH INSTITUTIONS. UNDER AN NIH/OTT PARTNERSHIP INTERMEDIARY AGREEMENT, BHI WILL EMPLOY AND PLACE ENTREPRENEURS-IN-RESIDENCE (EIR) WITHIN OTT TO EVALUATE, IDENTIFY AND LICENSE INTRAMURAL TECHNOLOGIES IN THE AREAS OF DRUGS, VACCINES, THERAPEUTICS, DIAGNOSTICS AND MEDICAL DEVICES FROM THE INTRAMURAL RESEARCH PROGRAMS AT BOTH THE NIH AND THE FOOD AND DRUG ADMINISTRATION(FDA). AN NIH EIR IS AN INDUSTRY EXPERT WITH SCIENTIFIC, ENTREPRENEURIAL/MANAGERIAL AND FINANCIAL EXPERIENCEWHO WORKS SIDE BY SIDE WITH NIH SCIENTISTS TO IDENTIFY, EVALUATE AND SUPPORT THE DEVELOPMENT OF NEW START-UP COMPANIES BASED UPON TECHNOLOGY LICENSE AGREEMENTS FROM OTT. THE INNOVATE UMBC PROGRAM PROVIDES APPLIED TRAINING FOR POST-DOCTORAL FELLOWS, RESEARCH SCIENTISTS, AND OTHER PROFESSIONALS WHO WANT TO START LIFE SCIENCE-BASED COMPANIES. THE PROGRAM WAS LAUNCHED IN 2010 WITH A 3-YEAR FUNDING GRANT FROM THE NATIONAL SCIENCE FOUNDATION(NSF). THE UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (UMBC) WILL OFFER THE PROGRAM AT THE UNIVERSITIES AT SHADY GROVE'S CAMPUS IN MONTGOMERY COUNTY, MARYLAND. THE PROGRAM IS INTENDED FOR SCIENTISTS INTERESTED IN COMMERCIALIZING BIOMEDICAL TECHNOLOGY. PARTNERS IN THE PROGRAM ARE BIOHEALTH INNOVATION, INC. AND THE MONTGOMERY COUNTY DEPARTMENT OF ECONOMIC DEVELOPMENT. 2752127 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 10 0 1 14 1 0 0 0 0 0 0 0 0 0 0 0 0 X 24 23 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 1 0 0 MD X LYNNE BRISBANE 3016370699 1 CHURCH STREET 801 ROCKVILLE MD 20850 RICHARD BENDIS PRESIDENT & CEO 40.00 X X 522326 0 37003 PETE BRISKMAN CHAIR 2.00 X X 0 0 0 CHRISTINE DINGIVAN VICE CHAIR 2.00 X X 0 0 0 CHARLES MORTON SECRETARY 2.00 X X 0 0 0 DAVE LEMUS TREASURER 2.00 X X 0 0 0 SALLY ALLAIN BOARD MEMBER 2.00 X 0 0 0 JARROD BORKAT BOARD MEMBER 2.00 X 0 0 0 CHRISTOPHER CALLAGHAN BOARD MEMBER 2.00 X 0 0 0 DONNA EDMONDS BOARD MEMBER 2.00 X 0 0 0 WILLIAM HEARL BOARD MEMBER 2.00 X 0 0 0 JUERGEN KLENK BOARD MEMBER 2.00 X 0 0 0 ANTHONY LAKAVAGE BOARD MEMBER 2.00 X 0 0 0 JOEL MARCUS BOARD MEMBER 2.00 X 0 0 0 KURT NEWMAN BOARD MEMBER 2.00 X 0 0 0 JAY PERMAN BOARD MEMBER 2.00 X 0 0 0 JOHN SACKETT BOARD MEMBER 2.00 X 0 0 0 AUBREY WATKINS BOARD MEMBER 2.00 X 0 0 0 SRJUANA CHERUKURI BOARD MEMBER (MAR-DEC) 2.00 X 0 0 0 RONALD KURZ BOARD MEMBER (MAY-DEC) 2.00 X 0 0 0 TYRELL RIVERS BOARD MEMBER (MAY-DEC) 2.00 X 0 0 0 RAYMOND BLANCHARD BOARD MEMBER (JUN-DEC) 2.00 X 0 0 0 DAN MALLON BOARD MEMBER (JUN-DEC) 2.00 X 0 0 0 AIME SMART BOARD MEMBER (AUG-DEC) 2.00 X 0 0 0 STEVEN ROBERTS BOARD MEMBER (SEPT-DEC) 2.00 X 0 0 0 LYNNE BRISBANE VP OF FINANCE, OPERATIONS, HR 40.00 X 163677 0 4911 SARAH MILLER MANAGING DIRECTOR, ECON 40.00 X 157297 0 4972 ETHEL RUBIN ENTREPRENEUR IN RESIDENCE 40.00 X 260858 0 13042 JOHN SULLIVAN ENTREPRENEUR IN RESIDENCE 40.00 X 222960 0 7039 1327118 0 66967 5 0 1 0 0 2603492 64542 736825 3404859 CONTRACT REVENUE 541700 660147 660147 660147 4065006 660147 0 0 X 522326 323842 83572 114912 1235342 765912 197655 271775 174837 108399 27974 38464 96554 59863 15449 21242 3600 2232 576 792 27228 27228 1219383 1196802 9508 13073 88500 54870 14160 19470 1957 1283 284 390 81512 50537 13042 17933 94076 58327 15052 20697 26729 26729 46279 46279 10296 6384 1647 2265 PROGRAM EXPENSES 38454 38454 SPONSORHIPS AND MEMBERS 19700 12214 3152 4334 3686773 2752127 409299 525347 969479 507339 3645 398845 367250 450100 450100 3312086 4114123 5134155 5438812 192350 251110 243006 93767 435356 344877 X 4698799 5093935 4698799 5093935 5134155 5438812 378233 16903 0 X X 0 1 X 1 0 X 2164046 2635961 2279895 2936434 3404859 13421195 2164046 2635961 2279895 2936434 3404859 13421195 2085570 11335625 50599 34600 33600 118799 13539994 0.83720 0.84240 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 INVESTMENTS IN BHI MANAGEMENT 450100 C 450100 DUE FROM AFFILIATES 4028192 SECURITY DEPOSITS 7887 RIGHT OF USE (OFFICE LEASE) 78044 4114123 OPERATING LEASE LIABILITY 93767 93767 X PART X, LINE 2: THE ORGANIZATION EVALUATES UNCERTAINTY IN INCOME TAX POSITIONS BASED ON A MORE-LIKELY-THAN-NOT RECOGNITION STANDARD. IF THAT THRESHOLD IS MET, THE TAX POSITION IS THEN MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED UPON ULTIMATE SETTLEMENT. AS OF DECEMBER 31, 2022 AND 2021, THERE ARE NO ACCRUALS FOR UNCERTAIN TAX POSITIONS. IF APPLICABLE, THE ORGANIZATION RECORDS INTEREST AND PENALTIES AS A COMPONENT OF INCOME TAX EXPENSE. TAX YEARS FROM 2018 THROUGH THE CURRENT YEAR REMAIN OPEN FOR EXAMINATION BY TAX AUTHORITIES. X X 0 0 0 0 0 0 0 1 0 RICHARD BENDIS PRESIDENT & CEO 340506 0 181820 0 0 0 16081 0 20922 0 559329 0 0 0 ETHEL RUBIN ENTREPRENEUR IN RESIDENCE 260858 0 0 0 0 0 13042 0 0 0 273900 0 0 0 JOHN SULLIVAN ENTREPRENEUR IN RESIDENCE 222960 0 0 0 0 0 7039 0 0 0 229999 0 0 0 LYNNE BRISBANE VP OF FINANCE, OPERATIONS, HR 163677 0 0 0 0 0 4911 0 0 0 168588 0 0 0 SARAH MILLER MANAGING DIRECTOR, ECON 157297 0 0 0 0 0 4972 0 0 0 162269 0 0 0 PART I, LINE 7 THE ORGANIZATION PROVIDED BONUS COMPENSATION TO ITS CEO. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM, AND REVIEWED BY THE ACCOUNTANT AND PRESIDENT AND CEO BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 15A THE LEVEL OF EXECUTIVE COMPENSATION WAS FIRST REVIEWED BY AN INDEPENDENT OUTSIDE CONSULTANT WHO REPORTED ON SIMILAR COMPENSATION LEVELS AT COMPARABLE ORGANIZATIONS BY SIZE, TYPE AND GEOGRAPHIC AREA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES IT'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENT AVAILABLE TO THE PUBLIC ON A CASE BY CASE BASIS. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 1,196,802. MANAGEMENT AND GENERAL EXPENSES 9,508. FUNDRAISING EXPENSES 13,073. TOTAL EXPENSES 1,219,383. FORM 990, PART XII, LINE 2C THE AUDIT OVERSIGHT PROCESS HAS REMAINED UNCHANGED FROM THE PREVIOUS YEAR. BHI MANAGEMENT INC 1 CHURCH STREET 801 ROCKVILLE MD 20850 464884282 HEALTH RELATED PRODUCTS MD BIOHEALTH INNOVATION INC C 1.00000 1 RELEVANT HEALTH HOLDINGS - I 1 CHURCH STREET 801 ROCKVILLE MD 20850 352548431 HEALTH TECH STARTUP ACCELERATOR MD BIOHEALTH INNOVATION INC C 0.70000 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 BHI MANAGEMENT INC O 2423327 FMV BHI MANAGEMENT INC N 210627 FMV